Literature DB >> 34087146

Adjuvant immunotherapy in muscle-invasive urothelial carcinoma.

Alessandro Rizzo1, Veronica Mollica1, Francesco Massari2.   

Abstract

Entities:  

Year:  2021        PMID： 34087146     DOI： 10.1016/S1470-2045(21)00202-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

Review 1.  Genomics and Immunomics in the Treatment of Urothelial Carcinoma.

Authors:  Veronica Mollica; Francesco Massari; Alessandro Rizzo; Roberto Ferrara; Arjun K Menta; Jacob J Adashek
Journal:  Curr Oncol       Date:  2022-05-12       Impact factor: 3.109

Review 2.  Pathologic Complete Response in Urothelial Carcinoma Patients Receiving Neoadjuvant Immune Checkpoint Inhibitors: A Meta-Analysis.

Authors:  Alessandro Rizzo; Veronica Mollica; Matteo Santoni; Gennaro Palmiotti; Francesco Massari
Journal:  J Clin Med       Date:  2022-02-17       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.